The Chicago Board Options Exchange (Cboe) has filed to list Canary Capital’s staked Injective ETF which could be the third staked crypto ETF in the U.S., following Solana and Ether.
If approved, the ETF will allow traditional investors to engage with the Injective protocol and potentially improve liquidity and interest in INJ, which currently trades at approximately 15.10 USD.
Recent SEC guidance favors staking practices, suggesting they are not classified as securities. This backdrop may push the proposed ETF towards approval.
Leave a Reply